Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. (Q50851551)
Jump to navigation
Jump to search
scientific article published on 16 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. |
scientific article published on 16 May 2016 |
Statements
1 reference
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. (English)
1 reference
Christopher D Buckley
1 reference
Jurgen van Melckebeke
1 reference
James Dale
1 reference
C Martina Messow
1 reference
Alexander McConnachie
1 reference
Andrew Walker
1 reference
Robin Munro
1 reference
John McLaren
1 reference
Euan McRorie
1 reference
Jon Packham
1 reference
John Harvie
1 reference
Peter Taylor
1 reference
Ernest Choy
1 reference
Costantino Pitzalis
1 reference
Iain B McInnes
1 reference
16 May 2016
1 reference
1 reference
388
1 reference
10041
1 reference
239-247
1 reference
Identifiers
1 reference